Molecular programs defining tumor-specific T-cell dysfunction and reprogrammability.

被引：0
|
作者：
Schietinger, Andrea [1 ]
机构：
[1] Sloan Kettering Inst, New York, NY USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2020年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA14
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [21] IMPLICATIONS OF LEUKOREGULIN TO AUTOLOGOUS TUMOR-SPECIFIC HUMAN T-CELL POPULATIONS
    SLINGLUFF, CL
    SEIGLER, HF
    DARROW, TL
    EVANS, CH
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (04): : 387 - 394
  • [22] IN-VIVO DETECTION OF FLUORESCENT TUMOR-SPECIFIC CYTOTOXIC T-CELL CLONES
    TOES, REM
    DENHAAN, JMM
    FELTKAMP, MCW
    BLOM, RJJ
    MELIEF, CJM
    CLAASSEN, E
    KAST, WM
    JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 163 (01) : 23 - 32
  • [23] Tumor-Secreted Extracellular Vesicles Regulate T-Cell Costimulation and Can Be Manipulated To Induce Tumor-Specific T-Cell Responses
    Zhao, Xianda
    Yuan, Ce
    Wangmo, Dechen
    Subramanian, Subbaya
    GASTROENTEROLOGY, 2021, 161 (02) : 560 - +
  • [24] T-cell clonotype convergence in colorectal cancer driven by tumor-specific neoantigens
    Machado, Jose C.
    Reis, Joana
    Fernandes, Margarida
    Silva, Rafaela
    Cirnes, Luis
    Carneiro, Fatima
    Costa, Jose L.
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Bcl-2 overexpression enhances tumor-specific T-cell survival
    Charo, J
    Finkelstein, SE
    Grewal, N
    Restifo, NP
    Robbins, PF
    Rosenberg, SA
    CANCER RESEARCH, 2005, 65 (05) : 2001 - 2008
  • [26] Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
    Jena, Bipulendu
    Dotti, Gianpietro
    Cooper, Laurence J. N.
    BLOOD, 2010, 116 (07) : 1035 - 1044
  • [27] ANTIGEN-PROCESSING - WHERE TUMOR-SPECIFIC T-CELL RESPONSES BEGIN
    BENNINK, JR
    ANDERSON, R
    BACIK, I
    COX, J
    DAY, P
    DENG, YP
    LAPHAM, C
    LINK, H
    RUSS, G
    YEWDELL, JW
    JOURNAL OF IMMUNOTHERAPY, 1993, 14 (03): : 202 - 208
  • [28] Thymocyte selection-associated HMG box protein TOX is a master regulator of tumor-specific T-cell dysfunction
    Scott, Andrew C.
    Camara, Steven
    Lauer, Peter
    Synder, Alexandra
    Zamarin, Dmitriy
    Walther, Tyler
    Levy, Olivier
    Glickman, Michael
    Kaye, Jonathan
    Philip, Mary
    Schietinger, Andrea
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [29] Personalization of T-Cell Therapy Using a High-Throughput Platform to Identify Tumor-Specific T-Cell Receptors
    Zong, Shan
    Cooper, Laurence J. N.
    McNamara, George T.
    Torikai, Hiroki
    BLOOD, 2016, 128 (22)
  • [30] INTERFERON-GAMMA-PRODUCING TUMOR INDUCES HOST TUMOR-SPECIFIC T-CELL RESPONSES
    TERAMURA, Y
    WATANABE, Y
    KAN, N
    MASUDA, T
    KURIBAYASHI, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (06): : 689 - 696
12345